Showing results (111-120 of 156) with videos related to
Sort By:
Pageof 16
Hepatic Oncology|March 19, 2016
Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond?Lynn Jeanette Savic, Julius Chapiro, Gregor Duwe, et al.Hepatic Oncology|December 1, 2015
Molecular classification of hepatocellular carcinoma: potential therapeutic implicationsNicolas Goossens, Xiaochen Sun, Yujin HoshidaHepatic Oncology|April 22, 2025
Advancing precision medicine in hepatocellular carcinoma: current challenges and future directions in liquid biopsy, immune microenvironment, single nucleotide polymorphisms, and conversion therapyMiho Akabane, Yuki Imaoka, Jun Kawashima, et al.Hepatic Oncology|April 11, 2020
The role of the innate immune system in the development and treatment of hepatocellular carcinomaChristoph Roderburg, Alexander Wree, Münevver Demir, et al.Hepatic Oncology|November 12, 2021
Transarterial chemoembolization alone or followed by bevacizumab for treatment of colorectal liver metastasesGiammaria Fiorentini, Donatella Sarti, Michele Nardella, et al.Hepatic Oncology|March 8, 2021
Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinomaPierre Nahon, Manon Allaire, Jean-Charles Nault, et al.Hepatic Oncology|March 8, 2021
Hepatitis B-related hepatocellular carcinoma and stress: untangling the host immune response from clinical outcomesPeter D Block, Brianna Shinn, Jin Hyang Kim, et al.Hepatic Oncology|September 30, 2022
Pathological complete response with immunotherapy and brachytherapy to 15 metastatic liver lesions in a single patientGokula Kumar Appalanaido, Muhamad Zabidi Ahmad, Syadwa Abdul Shukor, et al.Hepatic Oncology|September 8, 2018
Interview: Challenges and prospects for liver cancer management: treatment, prevention and collaborationShahid A KhanHepatic Oncology|September 8, 2018
Assessing resectability in cholangiocarcinomaTsuyoshi Sano, Yasuhiro Shimizu, Yoshiki Senda, et al.Pageof 16